RUNX3 and gallbladder cancer: Cai et al. demonstrated that RUNX3 expression is down-regulated in gallbladder cancer due to DNMT1-mediated promoter hypermethylation, and its downregulation is associated with a poor prognosis of patients with gallbladder cancer [89].